Nephros GAAP EPS of $0.05 beats by $0.03, revenue of $5.6M beats by $0.11M
Nephros reported Q3 GAAP EPS of $0.05, beating estimates by $0.03, with revenue of $5.6M, up 16.7% Y/Y and exceeding expectations by $0.11M. Net income rose to $0.5M from $0.3M Y/Y, and adjusted EBITDA increased to $0.6M from $0.4M.
How this was made
The 30-second read
Why it matters
The earnings surprise may trigger a short‑term rally, but the small absolute numbers limit broader market impact.
Market read
Micro‑cap earnings beat provides a modest trading opportunity; price move likely limited to a few percent.
What to watch
Potential upcoming capital raise or regulatory changes in water treatment could affect future performance.
Background
Nephros (NEPH) released its Q3 2026 earnings, reporting a GAAP EPS beat and revenue beat versus analyst expectations.
Ticker impact
Q3 2026 GAAP EPS of $0.05 beats expectations by $0.03 and revenue of $5.6M beats by $0.11M, marking the first earnings release for Nephros.
likely modest upside as the market prices in the earnings beat
Micro‑cap stocks often react sharply to surprise earnings; the beat is modest but positive.
Market effects
Limited; Nephros operates in water treatment, a niche sector with minimal broader impact.
US micro‑cap market may see slight uplift in similar biotech‑water firms.
Low; the company is small and primarily US‑focused.
Counterpoint
The beat is modest and may already be priced in; investors could be cautious of earnings volatility.
Key entities
- companyNephros, Inc.
US‑listed water‑treatment firm (NASDAQ: NEPH).
